Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$132M |
| 2 |
Newmont
NEM
|
+$67.7M |
| 3 |
Corteva
CTVA
|
+$65.9M |
| 4 |
Amcor
AMCR
|
+$58.2M |
| 5 |
Alibaba
BABA
|
+$48.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$128M |
| 2 |
Apple
AAPL
|
+$93M |
| 3 |
GG
Goldcorp Inc
GG
|
+$78.3M |
| 4 |
Microsoft
MSFT
|
+$73.5M |
| 5 |
Pfizer
PFE
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Healthcare | 14.68% |
| 3 | Consumer Discretionary | 11.95% |
| 4 | Communication Services | 10.15% |
| 5 | Industrials | 9.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Kforce
KFRC
$1.04B
| $1.5M | ﹤0.01% |
42,800
| – | – |
|
|
SEMG
1877
DELISTED
SEMGROUP CORPORATION
SEMG
| $1.5M | ﹤0.01% |
125,041
+16,900
| +16% | +$224K |
|
1878
Onto Innovation
ONTO
$14.3B
| $1.5M | ﹤0.01% |
43,200
+1,200
| +3% | +$38.4K |
|
1879
Pitney Bowes
PBI
$2.33B
| $1.5M | ﹤0.01% |
350,200
+8,300
| +2% | +$44.5K |
|
1880
Acco Brands
ACCO
$402M
| $1.5M | ﹤0.01% |
190,200
+2,900
| +2% | +$23.8K |
|
1881
Amkor Technology
AMKR
$13.1B
| $1.5M | ﹤0.01% |
200,600
+4,100
| +2% | +$32.1K |
|
|
HTZ
1882
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $1.49M | ﹤0.01% |
93,639
-11,953
| -11% | -$180K |
|
1883
MBIA
MBI
$257M
| $1.49M | ﹤0.01% |
160,300
+3,300
| +2% | +$30.8K |
|
1884
Alaunos Therapeutics
TCRT
$4.84M
| $1.49M | ﹤0.01% |
1,699
+178
| +12% | +$122K |
|
|
GTHX
1885
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.48M | ﹤0.01% |
48,400
+4,300
| +10% | +$90.5K |
|
1886
NETGEAR
NTGR
$627M
| $1.48M | ﹤0.01% |
58,600
+1,100
| +2% | +$32K |
|
|
RARX
1887
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $1.48M | ﹤0.01% |
49,300
+1,700
| +4% | +$38.9K |
|
1888
Cooper-Standard Automotive
CPS
$504M
| $1.48M | ﹤0.01% |
32,300
| – | – |
|
|
FSP
1889
Franklin Street Properties
FSP
$45.3M
| $1.47M | ﹤0.01% |
199,563
+4,100
| +2% | +$31.1K |
|
1890
Opko Health
OPK
$1.04B
| $1.47M | ﹤0.01% |
598,900
-13,300
| -2% | -$29K |
|
1891
MacroGenics
MGNX
$259M
| $1.46M | ﹤0.01% |
86,200
+3,500
| +4% | +$60.1K |
|
1892
Skywest
SKYW
$4.18B
| $1.46M | ﹤0.01% |
24,100
+500
| +2% | +$29.6K |
|
1893
Vericel Corp
VCEL
$2.25B
| $1.46M | ﹤0.01% |
77,400
+2,400
| +3% | +$40.9K |
|
1894
M/I Homes
MHO
$3.74B
| $1.46M | ﹤0.01% |
51,200
+700
| +1% | +$19.7K |
|
|
NXRT
1895
NexPoint Residential Trust
NXRT
$641M
| $1.45M | ﹤0.01% |
35,109
+1,500
| +4% | +$58.6K |
|
1896
Stock Yards Bancorp
SYBT
$2.58B
| $1.45M | ﹤0.01% |
40,223
+800
| +2% | +$27.7K |
|
|
CJ
1897
DELISTED
C&J Energy Services, Inc.
CJ
| $1.45M | ﹤0.01% |
123,000
+12,500
| +11% | +$171K |
|
|
STMP
1898
DELISTED
Stamps.com, Inc.
STMP
| $1.45M | ﹤0.01% |
31,966
+700
| +2% | +$40.1K |
|
1899
Pacific Biosciences
PACB
$357M
| $1.45M | ﹤0.01% |
238,946
-5,300
| -2% | -$37.2K |
|
|
USCR
1900
DELISTED
U S Concrete, Inc.
USCR
| $1.45M | ﹤0.01% |
29,100
| – | – |
|
Similar funds
Swiss National Bank's Q2 2019 Portfolio in Review
As of Q2 2019, Swiss National Bank held 2,619 positions worth $92.7B, up 1.7% from $91.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Swiss National Bank's Q2 2019 filing shows 112 new, 1,554 increased, 696 reduced and 65 closed positions. Its largest new stake was Dow Inc: 2,494,044 shares worth $123M. The largest sale was DuPont de Nemours, an estimated $128M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2019 buy was Dow Inc: 2,494,044 shares worth $123M.
- Swiss National Bank added most to Newmont in Q2 2019, an estimated $67.7M increase.
- Swiss National Bank's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $128M.
- Swiss National Bank fully exited Goldcorp Inc in Q2 2019, selling an estimated $78.3M.
- Swiss National Bank's ten largest holdings make up 18% of its $92.7B portfolio in Q2 2019.
- Swiss National Bank opened 112 new positions and closed 65 in Q2 2019.
- Swiss National Bank's portfolio value rose 1.7% quarter-over-quarter to $92.7B.
Based on Swiss National Bank's 13F filing for Q2 2019, filed 2 Aug 2019.